🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 17 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 31/01/2001 | 48,42 | 50,76 | 46,32 | 48,42 | -0,96% | 9,18% | 99.493 |
| 30/01/2001 | 51,00 | 52,17 | 48,66 | 48,89 | -6,28% | 6,88% | 80.097 |
| 29/01/2001 | 51,00 | 52,40 | 50,06 | 52,17 | +1,36% | 4,59% | 84.184 |
| 26/01/2001 | 47,49 | 52,87 | 47,49 | 51,47 | -5,17% | 11,33% | 121.374 |
| 25/01/2001 | 53,81 | 54,27 | 52,87 | 54,27 | +0,87% | 2,61% | 72.108 |
| 24/01/2001 | 54,04 | 54,51 | 52,87 | 53,81 | +0,00% | 3,03% | 210.420 |
| 23/01/2001 | 54,04 | 54,51 | 52,17 | 53,81 | +0,88% | 4,33% | 239.809 |
| 22/01/2001 | 52,87 | 54,27 | 52,64 | 53,34 | +3,17% | 3,10% | 205.905 |
| 19/01/2001 | 54,27 | 54,98 | 51,23 | 51,70 | +0,00% | 6,90% | 246.087 |
| 18/01/2001 | 46,79 | 51,70 | 46,09 | 51,70 | +9,95% | 12,00% | 75.234 |
| 17/01/2001 | 48,95 | 49,59 | 46,32 | 47,02 | -3,37% | 6,69% | 55.517 |
| 16/01/2001 | 45,62 | 50,30 | 45,62 | 48,66 | +6,12% | 10,26% | 86.322 |
| 12/01/2001 | 44,21 | 47,02 | 44,04 | 45,85 | +0,51% | 6,75% | 37.483 |
| 11/01/2001 | 44,68 | 45,85 | 44,21 | 45,62 | +2,09% | 3,66% | 29.789 |
| 10/01/2001 | 41,17 | 46,09 | 41,17 | 44,68 | -3,54% | 11,93% | 59.364 |
| 09/01/2001 | 43,04 | 47,49 | 43,04 | 46,32 | +7,03% | 10,33% | 53.513 |
| 08/01/2001 | 45,62 | 45,85 | 42,34 | 43,28 | -4,64% | 7,69% | 67.753 |
| 05/01/2001 | 48,89 | 50,76 | 45,38 | 45,38 | -7,62% | 11,00% | 64.788 |
| 04/01/2001 | 54,98 | 55,21 | 48,19 | 49,13 | -11,02% | 12,77% | 128.106 |
| 03/01/2001 | 51,00 | 55,21 | 50,76 | 55,21 | +7,27% | 8,72% | 67.860 |
| 02/01/2001 | 51,47 | 54,51 | 48,89 | 51,47 | -1,79% | 10,91% | 56.639 |
| 29/12/2000 | 51,93 | 54,04 | 51,70 | 52,40 | +0,00% | 4,50% | 45.552 |
| 28/12/2000 | 50,76 | 52,87 | 49,83 | 52,40 | +0,45% | 5,99% | 56.639 |
| 27/12/2000 | 45,85 | 52,17 | 45,85 | 52,17 | +8,25% | 13,78% | 60.487 |
| 26/12/2000 | 46,09 | 50,30 | 45,85 | 48,19 | +0,98% | 9,64% | 52.552 |
| 22/12/2000 | 43,57 | 49,13 | 43,51 | 47,72 | +10,87% | 12,89% | 74.299 |
| 21/12/2000 | 39,30 | 43,98 | 39,30 | 43,04 | +5,75% | 11,90% | 126.023 |
| 20/12/2000 | 46,32 | 46,79 | 40,24 | 40,70 | -14,71% | 14,14% | 118.168 |
| 19/12/2000 | 47,49 | 48,19 | 47,02 | 47,72 | +0,99% | 2,46% | 99.333 |
| 18/12/2000 | 48,66 | 49,13 | 46,79 | 47,26 | -1,94% | 4,81% | 79.776 |